about
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...
Read More
49.16
-1.10
(-2.19%)
18.8M
XNYS Volume
XNYS 13 Nov, 2025 4:30 PM (EST)
Low Financial Strength
Mid Valuation
Technically Neutral
Await Turnaround
These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks.
View Similar
Embed DVM
Novo Nordisk ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..